Numerous reports confirm that APOL1 risk alleles increase the risk for focal segmental glomerulosclerosis, HIV-associated nephropathy, and COVID-19-associated nephropathy, all of which fall within the spectrum of APOL1-mediated kidney disease (AMKD) (7, 10–12). The gene discussed is APOL1; the disease is focal segmental glomerulosclerosis.